应用抗血小板及抗凝药物治疗糖尿病的进展
摘要
糖尿病的并发症主要是血管性并发症,多以各级动脉病变为特征改变,动脉病变后导致栓塞风险增高,因此抗血小板及抗凝治疗近年日益受到重视.本文对此方面发展进行了回顾.
出处
《广东医学》
CAS
CSCD
北大核心
2011年第21期2882-2884,共3页
Guangdong Medical Journal
参考文献31
-
1PHILLIPS B D, LAUFGRABEN M J. Diabetic muscle infarction in a 28 - year - old woman : case report and review of the literature [J]. The Endocrinologist, 2008, 18(4) : 187 -190.
-
2TRUJILLO SANTOS A J. Diabetic muscle infarction: an underdi- agnosed complication of long - standing diabetes [ J ]. Diabetes Care, 2003, 26(1): 211 -215.
-
3RAHMAN I, NARASIMHAN K, BAIR C, et al. Diabetic myone- crosis[J]. The Endocrinologist, 2009, 19(4) : 169 -170.
-
4王椿,冉兴无,王华,赵铁耘,童南伟,宋彬,步宏,罗燕,田浩明,李秀钧.糖尿病性肌梗塞六例[J].中华内分泌代谢杂志,2004,20(4):314-317. 被引量:8
-
5ANGIOLILLO D J, SHOEMAKER S B, DESAI B, et al. Ran- domized comparison of a high clopidogrel maintenance dose in pa- tients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTI- MUS) study[J]. Circulation, 2007, 115(6) : 708 -716.
-
6ANGIOLILLO D J, CAPRANZANO P, GOTO S, et al. A random- ized study assessing the impact of cilostazol on platelet function pro- files in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS - 2 study [ J ]. Eur Heart J, 2008, 29(18): 2202-2211.
-
7ANGIOLILLO D J, BADIMON J J, SAUCEDO J F, et al. A phar- macodynamic comparison of prasugrel vs. high - dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti - Platelet Therapy in Diabetes Melli- tUS (OPTIMUS) -3 Trial[J]. Eur Heart J, 2011,32(7) : 838 - 846.
-
8SINGER D E, CHANG Y, FANG M C, et al. The net clinical benefit of warfarin anticoagulation in atrial fibrillation[ J]. Ann In- tern Med, 2009, 151 (5) : 297 - 305.
-
9CHRISTOPHER D S. The Johns Hopkins POC - IT DIABETES Guide[ M/OL]. Baltimore, 2011 : http: //www. hopkinsguides. corn/hopkins/ub/view/Johns_Hopkins_Diabetes_Guide/547119/all/Periphe- ral_Vascular_Disease#18574279.
-
10LEE G, DENNIS A. Cecil Medicine [ M]. 23rd Ed. Philadel- phia: Saunders Elsevier, 2007: 561.
二级参考文献27
-
1邬寿贞,查跃英.下肢静脉溃疡的病因学研究和治疗现状[J].医师进修杂志(外科版),2005,28(8):59-60. 被引量:15
-
2Angervall L, Stener B. Tumoriform focal muscular degeneration in two diabetic patients. Diabetologia, 1965, 1:39-42.
-
3Trujillo-Santos AJ. Diabetic muscle infarction: an underdiagnosed complication of long-standing diabetes. Diabetes Care, 2003, 26:211-215.
-
4Ali A, Conti M, Massucco P, et al. Diabetic muscle infarction associated with multiple autoimmune disorders, IgA deficiency and a catastrophically poor glycaemic control: a case report. Diabetes Nutr Metab, 2003,16:134-137.
-
5Chow KM, Szeto CC, Griffith JF, et al. Unusual muscle pain in two patients with diabetic renal failure. Hong Kong Med J, 2002,8:368-371.
-
6Eady JL, Cobbs KF. Diabetic muscle infarction. J South Orthop Assoc, 1997,6:250-255.
-
7Willenberg HS, Hauner H, Scherbaum WA. A man with diabetes and a swollen leg. Lancet, 1999, 353:1527-1528.
-
8Barohn RJ, Kissel JT. Case-of-the-month: painful thigh mass in a young woman: diabetic muscle infarction. Muscle Nerve. 1992,15:850-855.
-
9Umpierrez GE, Stiles RG, Kleinbart J, et al. Diabetic muscle infarction. Am J Med, 1996,101:245-250.
-
10Jelinek JS, Murphey MD, Aboulafia AJ, et al. Muscle infarction in patients with diabetes mellitus: MR imaging findings. Radiology, 1999,211:241-247.
共引文献19
-
1崔本银.糖尿病酮症酸中毒并发额肌梗死1例[J].疑难病杂志,2005,4(4):236-236. 被引量:2
-
2张杰,王瑾.糖尿病合并真性红细胞增多症伴发肌梗塞1例[J].中国误诊学杂志,2006,6(1):190-190.
-
3栾红军.糖尿病患者肌肉梗死的MRI诊断[J].临床放射学杂志,2006,25(7):655-657. 被引量:5
-
4冯梅,付平,崔天蕾,刘芳,胡章学.糖尿病肌梗死的循证诊断[J].中国实用内科杂志:临床前沿版,2006,26(10):1640-1643. 被引量:1
-
5梁元碧,廖永梅.糖尿病伴缝匠肌肌梗死1例[J].华西医学,2007,22(1):173-173.
-
6胡怡,刘立旻,张斌,高阳,熊盈,魏敏,毛宇强,陈松,陈思娇,宋今丹.醛固酮拮抗剂对代谢综合征合并慢性心力衰竭患者胰岛素抵抗指数和C-反应蛋白的影响[J].中国全科医学,2008,11(15):1332-1334. 被引量:10
-
7王庭俊,王中心,杨芳,陈纯娴.舒洛地特治疗2型糖尿病早期肾病的临床观察[J].医药世界,2009(12):769-771. 被引量:2
-
8李鹏,杨镛.下肢静脉性皮肤溃疡的治疗进展[J].中国医药导报,2010,7(10):15-16. 被引量:4
-
9何清华,周晓梅,唐晨,谭斌,张春龙,高学明.糖尿病肌梗塞1例[J].检验医学与临床,2010,7(16):1784-1785. 被引量:1
-
10高阳,陈思娇,杨红艳,李红燕,朱贺,郭英华,宋今丹.糖尿病肾病患者尿微量清蛋白与肌酐比值的相关因素研究[J].中国全科医学,2011,14(6):598-600. 被引量:41
-
1动物胰岛素和胰岛素类似物该如何选择?[J].糖尿病天地(文摘刊),2014,0(10):35-35.
-
2李明,马丹华,冯丹宇,孙骏.复方氨基酸注射液1540例不良反应的综合分析[J].药学与临床研究,2015,23(6):590-592. 被引量:16
-
3匡小虎,张抒扬.维生素D对心血管系统的影响[J].中华心血管病杂志,2012,40(5):446-448. 被引量:4
-
4杜蕾,马培奇.糖尿病治疗药物及其研究进展[J].中国制药信息,2005,21(8):17-22. 被引量:2
-
5张旭升.经皮冠脉介入治疗的并发症及防治[J].中国现代药物应用,2015,9(8):40-41. 被引量:4
-
6贾建朋,靳英红,吕彦宗,魏立业.苯磺酸左旋氨氯地平对原发性高血压患者血浆内皮素及肾功能的影响[J].河北医药,2009,31(13):1609-1610. 被引量:9
-
7朱沂,龙江,李红燕,周亚丽,谭毓绘,莫合塔尔,张晓莺,彭颜辉,张丽萍,海力,玛依努尔,牛晓珊,帕丽达,曼古努尔,施培培.水蛭素合用阿司匹林与单用阿司匹林或氯吡格雷治疗短暂性脑缺血发作的随机对照研究[J].中华脑血管病杂志(电子版),2008,2(2):70-74. 被引量:4
-
8国家食品药品监督管理局关注药品“文迪雅”安全性问题[J].中国医药技术与市场,2007,7(4):15-15.
-
9中国国家食品药品监督管理局关注药品“文迪雅”安全性问题[J].中华医学信息导报,2007,22(11):13-13.
-
10国家食品药品监督管理局关注“文迪雅”安全性问题[J].临床药物治疗杂志,2007,5(4):35-35.